Silicom CFO exercises options and sells 7,000 shares

Silicom Ltd. chief financial officer Gilad Eran indirectly exercised share options and sold shares held by a trustee.

Rhea-AI Filing Summary

Silicom Ltd. chief financial officer Gilad Eran indirectly exercised share options and sold shares held by a trustee. On 2026-08-06 he exercised options for 5,000 ordinary shares at 16.42 per share and then sold a total of 7,000 ordinary shares at prices of 46.56 and 44.44 per share.

All reported positions are held by a trustee under Silicom’s equity incentive plan. After these transactions he continues to hold indirect equity awards, including share options covering 10,000 ordinary shares at an exercise price of 15.01 per share and 7,333 restricted share units that vest in tranches over three years, subject to his continuous service.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Gilad Eran

Role CFO

Sold 7,000 shs ($311K)

Approx. gross sale proceeds $311K

Approx. exercise cost $82K

Type	Security	Shares	Price	Value
Exercise	Share Option (right to buy) F1, F2	5,000	$0.00	$0.00
Exercise	Ordinary shares F2	5,000	$16.42	$82K
Sale	Ordinary shares F2	25	$46.56	$1K
Sale	Ordinary shares F2	6,975	$44.44	$310K
holding	Share Option (right to buy) F4, F2	--	--	--
holding	Restricted Share Units F3, F5, F2	--	--	--

Holdings After Transaction: Share Option (right to buy) — 15,000 contracts for 10,000 underlying shares (Indirect, By Trustee); Ordinary shares — 0 shares (Indirect, By Trustee); Restricted Share Units — 7,333 contracts (Indirect, By Trustee)

Footnotes (5)

1. F1. On June 18, 2024 (the "Grant Date"), the Reporting Person was granted an aggregate of 10,000 options of which 50% were due to vest on the second anniversary of the Grant Date and 50% are due to vest on the third annual anniversary of the Grant date, subject to his continuous service relationship with the Issuer through each applicable vesting date.
2. F2. These securities are held by a trustee pursuant to the Issuer's equity incentive plan.
3. F3. Each restricted share unit (RSU) represents the right to receive, following vesting, one share of the Issuer.
4. F4. Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2025 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.
5. F5. Subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date, (a) 2,445 of the RSUs will vest and convert into ordinary shares one year after the grant date (which grant date is January 29, 2026), (b) 2,444 of the RSUs will vest and convert into ordinary shares on the second annual anniversary of the grant date and (c) 2,444 of the RSUs will vest and convert into ordinary shares on the three year anniversary of the grant date. If a vesting date falls on a non-business date, the next business date shall apply.

Key Figures

Options exercised: 5,000 shares at 16.42 per share Shares sold at 46.56: 25 shares at 46.56 per share Shares sold at 44.44: 6,975 shares at 44.44 per share +3 more

6 metrics

Options exercised 5,000 shares at 16.42 per share Share options exercised into ordinary shares on 2026-08-06

Shares sold at 46.56 25 shares at 46.56 per share Indirect sale of ordinary shares on 2026-08-06 by trustee

Shares sold at 44.44 6,975 shares at 44.44 per share Indirect sale of ordinary shares on 2026-08-06 by trustee

Net shares sold 7,000 shares Net buy/sell shares across reported transactions

Remaining options 10,000 underlying shares at 15.01 per share Indirect share options expiring 2033-06-18

Restricted share units 7,333 underlying shares Indirect RSU position following reported transactions

Key Terms

Share Option (right to buy), Restricted Share Units, equity incentive plan, Grant Date, +1 more

5 terms

Share Option (right to buy) financial

"security_title is listed as "Share Option (right to buy)" for derivatives"

Restricted Share Units financial

"security_title includes "Restricted Share Units" with underlying ordinary shares"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

equity incentive plan financial

"These securities are held by a trustee pursuant to the Issuer's equity incentive plan."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Grant Date financial

"On June 18, 2024 (the "Grant Date"), the Reporting Person was granted an aggregate of 10,000 options"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

vesting date financial

"subject to his continuous service relationship with the Issuer through each applicable vesting date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did SILICOM LTD. (SILC) CFO Gilad Eran report in this Form 4?

CFO Gilad Eran indirectly exercised options for 5,000 ordinary shares at 16.42 per share and sold 7,000 ordinary shares at 46.56 and 44.44 per share, all through a trustee under Silicom’s equity incentive plan.

How many SILICOM LTD. (SILC) shares did the CFO sell and at what prices?

Gilad Eran indirectly sold 7,000 ordinary shares of Silicom Ltd., including 25 shares at 46.56 per share and 6,975 shares at 44.44 per share, with all shares held by a trustee pursuant to the company’s equity incentive plan.

What stock options did SILICOM LTD. (SILC) CFO exercise in this filing?

On 2026-08-06, Gilad Eran exercised 5,000 share options, converting them into 5,000 ordinary shares at an exercise price of 16.42 per share. These options were part of a grant that vests in two equal tranches, subject to his continuous service.

What equity incentives does SILICOM LTD. (SILC) CFO still hold after these transactions?

After the reported trades, Gilad Eran continues to hold indirect awards, including share options over 10,000 ordinary shares at an exercise price of 15.01 per share and 7,333 restricted share units, each RSU representing one future ordinary share upon vesting.

Are the SILICOM LTD. (SILC) CFO’s reported holdings direct or indirect?

All reported positions are indirect holdings described as “By Trustee.” Footnotes state these securities are held by a trustee under Silicom’s equity incentive plan, meaning the trustee, not the CFO personally, is the registered holder of the shares and awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 09:08 AM Accepted by SEC EDGAR 08/06/2026 - 09:08 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gilad Eran

(Last) (First) (Middle)

14 ATIR YEDA ST

(Street)

KFAR-SAVA 4464323

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
SILICOM LTD. [ SILC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares	08/06/2026		M		5,000	A	$16.42	7,000	I	By Trustee(2)
Ordinary shares	08/06/2026		S		25	D	$46.56	6,975	I	By Trustee(2)
Ordinary shares	08/06/2026		S		6,975	D	$44.44	0	I	By Trustee(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	$16.42	08/06/2026		M			5,000	(1)	06/18/2032	Ordinary shares	5,000	$0.00	5,000	I	By Trustee(2)
Share Option (right to buy)	$15.01							(4)	06/18/2033	Ordinary Shares	10,000		10,000	I	By Trustee(2)
Restricted Share Units	(3)							(5)	(5)	Ordinary Shares	7,333		7,333	I	By Trustee(2)

Explanation of Responses:

1. On June 18, 2024 (the "Grant Date"), the Reporting Person was granted an aggregate of 10,000 options of which 50% were due to vest on the second anniversary of the Grant Date and 50% are due to vest on the third annual anniversary of the Grant date, subject to his continuous service relationship with the Issuer through each applicable vesting date.

2. These securities are held by a trustee pursuant to the Issuer's equity incentive plan.

3. Each restricted share unit (RSU) represents the right to receive, following vesting, one share of the Issuer.

4. Each option represents an option to purchase one share of the Issuer's ordinary shares upon vesting. The options were granted on June 18, 2025 (the "Grant Date") and will vest as follows: (a) 50% on the second annual anniversary of the Grant Date; and (b) 50% on the third annual anniversary of the Grant Date subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.

5. Subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date, (a) 2,445 of the RSUs will vest and convert into ordinary shares one year after the grant date (which grant date is January 29, 2026), (b) 2,444 of the RSUs will vest and convert into ordinary shares on the second annual anniversary of the grant date and (c) 2,444 of the RSUs will vest and convert into ordinary shares on the three year anniversary of the grant date. If a vesting date falls on a non-business date, the next business date shall apply.

	/s/ Gilad Eran	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)